C4. Respiratory infections - viral
Poster Session: Respiratory Infections - Viral
Ombeline Jollivet, MSc (she/her/hers)
Medical Evidence Generation lead, New products & Innovation team, Vaccines Medical department
Sanofi
Lyon, Rhone-Alpes, France
Sandra S. Chaves, MD, MSc
Sanofi Pasteur
Lyon, Languedoc-Roussillon, France
Christophe Carré, PhD
Sanofi
Marcy-L'Etoile, Rhone-Alpes, France
Chao-Yang Pan, MPH
California Department of Public Health, Center for Laboratory Sciences, Viral and Rickettsial Disease Laboratory
Richmond, California, United States
Hugo Guevara, MSc
California Department of Public Health, Center for Laboratory Sciences, Viral and Rickettsial Disease Laboratory
Richmond, California, United States
Debra Wadford, PhD
Laboratory Director
California Department of Public Health
Richmond, CA, United States
Nicola P. Klein, MD, PhD (she/her/hers)
Director, Kaiser Permanente Vaccine Study Center and Senior Research Scientist
Division of Research Kaiser Permanente Vaccine Study Center
Oakland, California, United States
Amber Hsiao, MPH
Senior Research Project Manager
Division of Research Kaiser Permanente Vaccine Study Center
Oakland, California, United States
Kamela Ng, PhD
Sanofi
Lyon, Rhone-Alpes, France
Ruvim Izikson, MD, MPH
Sanofi
Bridgewater, New Jersey, United States
Heidi Kabler, MD
Influenza Medical Director, Medical Affairs
Sanofi Pasteur
Swiftwater, New Jersey, United States
William T. Harvey, PhD
The Roslin Institute, University of Edinburgh
Edinburgh, Scotland, United Kingdom
Laurence Josset, MCU-PH, PharmD PhD
Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Team Virpath
Lyon, Rhone-Alpes, France
Clotilde El Guerche-Séblain, PhD
Sanofi
Lyon, Rhone-Alpes, France